Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

Delayed Data
As of Apr 20
 +0.28 / +3.46%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Clinuvel Pharmaceuticals Ltd have a median target of 25.66, with a high estimate of 25.66 and a low estimate of 25.66. The median estimate represents a +206.16% increase from the last price of 8.38.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Clinuvel Pharmaceuticals Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
Growthannually 104.73%


Growthquarterly --
Growthannually 821.07%
Key to the earnings and sales forecast charts.